Sofinnova Partners Launch $53 Million Medtech Acceleration Fund

Sofinnova Partners, a European venture capital firm specializing in Life Sciences, announced today the launch of MD Start III, which closed above its original target of €40 million. With this new medtech acceleration fund, Sofinnova Partners continues to reinforce its coverage across the Life Sciences sector, with funds operated by dedicated teams investing from seed to late stage.